Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Dressing up the bride

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Mar 08, 2023 5:17pm

45 Views

Post# 35326915

RE:RE:Dressing up the bride

Ok I get it that Pharma companies don't operate that way. They will pay billions for later stage stuff and won't bother with this thing, fine, but what about specialised player that just look at the legacy stuff and try to capitalise on it.

<< Previous

Bullboard Posts

Next >>

Victory Battery Metals acquires Utah and Saskatchewan uranium projects